Madrigal Pharmaceuticals, Inc. · NASDAQ:MDGL
Soergel David sold 1,042 Madrigal Pharmaceuticals, Inc. shares (Form 4)
Traded Jun 1, 2026 · Filed Jun 1, 2026
On Jun 1, 2026, Soergel David (Chief Medical Officer) sold 1,042 Madrigal Pharmaceuticals, Inc. shares at US$495.74 for US$517K under a trading plan, leaving 10,033 shares. Filed Jun 1, 2026 (Form 4).
- Sold
- 1,042 shares
- Price
- US$495.74
- Value
- US$517K
- Holding after
- 10,033 shares
- Trading plan
- Yes (Made under a plan set in advance)
- Role
- Chief Medical Officer
The filing in full
| Date | Security | Transaction | Shares | Price | Holding after | Ownership |
|---|---|---|---|---|---|---|
| Jun 1, 2026 | Common Stock | Sale | 1,042 | US$495.74 | 10,033 | Direct |
Source
Related
- Madrigal Pharmaceuticals, Inc.
- Soergel David
- Madrigal Pharmaceuticals, Inc. shareholders
- Form 4 · Soergel David · May 18, 2026
- Form 4 · Sibold William John · Sep 11, 2026
- Form 4 · Kelley Shannon T · Aug 20, 2026
- Form 4 · Reed John C · Aug 18, 2026
- Schedule 13G/A · BlackRock, Inc. · Jul 29, 2026
- Form 4 · Sibold William John · Jul 20, 2026